GLOW Peptide Blend for Research: BPC-157, TB-500, GHK-Cu
GLOW is a research blend of BPC-157, TB-500 and GHK-Cu. Its composition, how it differs from KLOW, and how a certificate should treat a three-component vial.
GLOW is a research blend of BPC-157, TB-500 and GHK-Cu. Its composition, how it differs from KLOW, and how a certificate should treat a three-component vial.
NAD+ is a dinucleotide coenzyme at the center of redox metabolism and the substrate of sirtuins, PARPs and CD38. Its research background, chemistry, and lot verification.
IGF-1 LR3 is an 83-residue analogue engineered to escape IGF-binding proteins in culture media. Why it exists, how it differs from native IGF-1, and lot verification.
AOD-9604 is a synthetic 16-residue fragment of hGH (177-191) from the fragment-mapping era of hormone research. Its background, disulfide checkpoint, and lot quality.
Kisspeptin-10 is the minimal active fragment of the KISS1 peptide family, a standard probe in receptor research. Its two research tracks, structure, and lot quality.
Sermorelin is GHRH(1-29) — the fragment that defined GHRH-receptor research and the baseline compound its analogues are measured against. Structure, literature, lot quality.
Adamax is an adamantane-modified analogue of Semax with a thinner but growing research literature. How it differs from its parent, and what its certificate should show.
5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. Its research background in NAD+ and methylation metabolism, and what its certificate should show.
PT-141 (bremelanotide) is a cyclic heptapeptide studied at melanocortin receptors. Its structure, its relationship to Melanotan II, and what its certificate should show.
CJC-1295 and Ipamorelin are distinct molecules with different receptor targets. What each is, why the pairing recurs in research, and how a blend certificate should treat them.